SpeichernDas Eingabefeld wird
gespeichert wenn Sie das Feld
verlassen oder hier klicken.
Xetra Frankfurt
Börse Xetra Frankfurt
ISIN US717081ER06
EUR
  • Pfizer
    Börse NYSE New York Stock Exchange
    ISIN US7170811035 WKN: 852009
    Symbol PFE
    USD
  • PFIZER INC
    Börse Börse Hamburg
    ISIN US717081ED10
    Symbol PFE
    EUR
  • Pfizer
    Börse Börse Stuttgart
    ISIN US717081DK61
    Symbol PFE
    EUR
  • Pfizer
    Börse Xetra Frankfurt
    ISIN US717081ER06
    Symbol PFE
    EUR
  • PFIZER INC
    Börse Börse Düsseldorf
    ISIN XS1574158082
    Symbol PFE
    EUR
  • PFIZER INC
    Börse Börse München
    ISIN US717081DZ31
    Symbol PFE
    EUR
  • PFIZER INC
    Börse Gettex System der Börse München
    ISIN US717081ES88
    Symbol PFE
    EUR
  • PFIZER INC
    Börse Tradegate System der Deutsche Börse AG (60%)
    ISIN US717081EQ23
    Symbol PFE
    EUR
  • PFIZER INC
    Börse Quotrix System der Börse Düsseldorf
    ISIN US717081DE02
    Symbol PFE
    EUR
  • PFIZER INC
    Börse Börse Frankfurt
    ISIN XS1574157357
    Symbol PFE
    EUR
  • Pfizer
    Börse Xetra Frankfurt
    ISIN US717081EY56
    EUR
  • Pfizer
    Börse Börse München
    ISIN US717081FA61
    EUR
  • Pfizer
    Börse SSE Stockholm Stock Exchange
    ISIN US717081EZ22
    Symbol PFE
    SEK
  • Pfizer
    Börse Bolsa Mexicana de Valore Mexiko-Stadt
    ISIN US717081EK52
    Symbol PFE
    MXN
  • Pfizer
    Börse Bolsa de Comercio de Buenos Aires
    ISIN US717081DV27
    USD
  • Pfizer
    Börse Bolsa Mexicana de Valore Mexiko-Stadt
    ISIN US717081DH33
    MXN
  • Pfizer
    Börse BUE
    ISIN US717081EV18
    USD
  • ISIN US717081EX73
    Symbol PFE
    EUR
  • Pfizer
    Börse OMXS
    ISIN US7170811035
    SEK
  • ISIN US717081EJ89
    EUR
  • PFIZER INC
    Börse SSE
    ISIN US717081EP40
ISIN US717081ER06
Symbol PFE
Währung EUR
Börse Xetra Frankfurt Zeitzone: Europe/Berlin
Firmenname Pfizer Inc
Marktkapitalisierung 197.500.079.920 (+- 10%)

Die einen sagen so, die anderen so... Es gibt 3 Datenquellen:

204.882.624.512 oder 216.419.000.000 oder 171.198.615.249

Mitarbeiter 83.400 (+- 6%)

Die einen sagen so, die anderen so... Es gibt 2 Datenquellen:

88.300 oder 78.500 Mitarbeiter

Anzahl Aktien 5.558.396.599
KGV 18.68 (+- 28%)

Die einen sagen so, die anderen so... Es gibt 2 Datenquellen:

23.97 oder 13.4

EBITDA 19.320.000.512
PEGRatio 4.9741
Buchwert 11.744

Zahlte zuletzt am 06.05.2021 eine Dividende von 0,39  . Seit damals wurde keine Dividende mehr ausgeschüttet Übersicht

Analystenmeinungen

Übersicht

Letzte Communitymeinungen

Ein User hat Pfizer abonniert.

Aktionärsstruktur der Pfizer Inc

1.790 News & Informationen zur Pfizer Aktie

  • Global Active Pharmaceutical Ingredients/API Market to Reach $274.8 Billion by 2026
    prnewswire.com

    Global Active Pharmaceutical Ingredients/API Market to Reach $274.8 Billion by 2026

    /PRNewswire/ — A new market study published by Global Industry Analysts Inc., (GIA) the premier market research company, today released its report titled…

  • Moderna Gains As UK Regulator Oks Covid Shot For Those Aged 12–17 By Investing.com
    investing.com

    Moderna Gains As UK Regulator Oks Covid Shot For Those Aged 12–17 By Investing.com

    Moderna Gains As UK Regulator Oks Covid Shot For Those Aged 12–17

  • Moderna Stock At $400. What Are The Risks?
    forbes.com

    Moderna Stock At $400. What Are The Risks?

    Moderna stock is up by about 2.5x year-to-date, trading at levels of about $390 per share as of Friday. The rally comes on the back of Moderna’s recent inclusion into the S&P 500 index and the emergence of new virus variants which are making a strong case for booster doses of Covid-19 shots…

  • Pfizer (PFE)/BioNTech Give First COVID Jab Booster Data to FDA
    zacks.com

    Pfizer (PFE)/BioNTech Give First COVID Jab Booster Data to FDA

    Pfizer (PFE)/BioNTech's (BNTX) booster dose of COVID-19 vaccine elicited antibody levels that were much higher than that seen after the two-dose primary schedule.

  • SEC Charges Biopharmaceutical Company Employee with Insider Trading
    sec.gov

  • Stocks That Hit 52-Week Highs On Tuesday
    benzinga.com

    Stocks That Hit 52-Week Highs On Tuesday

    Before 10 a.m. ET on Tuesday, 55 companies set new 52-week highs.
    Points of Interest: Apple (NASDAQ:AAPL) was the largest company by market …

  • Biden set to urge Covid-19 booster shots starting next month
    livemint.com

    Biden set to urge Covid-19 booster shots starting next month

    Biden administration is finalizing a plan expected to recommend Covid-19 booster shots eight months after people received their second dose. The plan is not yet finalized but an announcement could come as soon as this week

  • 15 Best Momentum Stocks To Invest In
    insidermonkey.com

    15 Best Momentum Stocks To Invest In

    The influx of retail investors on the market in the past few months has led to an increase in stock volatility.

  • U.K. Authorizes Moderna Covid-19 Vaccine for Use in Adolescents
    bloombergquint.com

    U.K. Authorizes Moderna Covid-19 Vaccine for Use in Adolescents

    (Bloomberg) — Britain’s drug regulator authorized Moderna Inc.’s Covid-19 shot for children as young as 12, though few are likely to receive it in the near term as the country remains an outlier in its policy on vaccinating kids.

    The U.K.

  • The Daily Biotech Pulse: Lilly Reorganizes Business Units In Neuroscience Focus, Helius Medical Spikes On Breakthrough Designation, Ra...
    news.google.com

    The Daily Biotech Pulse: Lilly Reorganizes Business Units In Neuroscience Focus, Helius Medical Spikes On Breakthrough Designation, Ra Medical Sells Dermatology Business

    Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 16) Bio-Rad Laboratories, Inc. (NYSE: BIO) Crinetics Pharmaceuticals, Inc. (NASDAQ: CRNX) Gilead Sciences, Inc. (NASDAQ: GILD) GlaxoSmithKline plc (NYSE: GSK) Johnson & Johnson (NYSE: JNJ) Laboratory Corporation of America Holdings (NYSE: LH) Monte Rosa Therapeutics, Inc. (NASDAQ: GLUE) NanoVibronix, Inc. (NASDAQ: NAOV) (announced intention to enter over-

  • No data shows need for booster vaccines presently: Dr Gagandeep Kang
    business-standard.com

    No data shows need for booster vaccines presently: Dr Gagandeep Kang

    Read more about No data shows need for booster vaccines presently: Dr Gagandeep Kang on Business Standard. According to Dr Kang, whether people will have more antibodies or be better protected with the booster dose is still not known

  • New Zealand to enter lockdown; Japan set to expand emergency
    businessmirror.com.ph

    New Zealand to enter lockdown; Japan set to expand emergency

    New Zealand Prime Minister Jacinda Ardern put the nation into a three-day lockdown after reporting the first community case of Covid since February. The country will be placed in lockdown at midnight tonight after discovery of a single case in Auckland, Ardern said at a news conference in Wellington. Auckland…

  • 5 things to know before the stock market opens Tuesday
    cnbc.com

    5 things to know before the stock market opens Tuesday

    Stock futures fell Tuesday morning as traders awaited the release of key economic data about the U.S. consumer.

  • If you have taken a Pfizer Covid-19 vaccine – here’s what you should know about a third ‘booster’ shot
    businesstech.co.za

    If you have taken a Pfizer Covid-19 vaccine – here’s what you should know about a third ‘booster’ shot

    Pharmaceutical companies Pfizer and BioNTech have submitted data to the US Food and Drug Administration (FDA) to support the evaluation of a third booster shot…

  • HK Raises Quarantine Time; New Zealand Local Case: Virus Update
    financialpost.com

    HK Raises Quarantine Time; New Zealand Local Case: Virus Update

    (Bloomberg) — Hong Kong will hike quarantine for medium-risk places to 14 days to curb the spread of the virus. Business groups in the city are already…

  • Wyeth sets repurchase price at Rs1,284.18 per share
    dawn.com

    Wyeth sets repurchase price at Rs1,284.18 per share

    The company intends to repurchase 396,579 shares comprising 27.90 per cent of the capital of the company.

  • Pfizer, BioNTech Submit COVID-19 Booster Vaccine Data To FDA
    markets.businessinsider.com

    Pfizer, BioNTech Submit COVID-19 Booster Vaccine Data To FDA

    (RTTNews) – Pfizer Inc. (PFE) and BioNTech SE (BNTX) have submitted phase 1 data to the U.S. Food and Drug Administration to support the evaluatio…

  • Pfizer submits initial data for COVID-19 vaccine booster authorization
    moneycontrol.com

    Pfizer submits initial data for COVID-19 vaccine booster authorization

    They said the third dose showed significantly higher neutralizing antibodies against the initial SARS-CoV-2 virus compared to the two doses as well as against the Beta and the highly infectious Delta variants.

  • Pfizer: The Rally Is Far From Finished
    gurufocus.com

    Pfizer: The Rally Is Far From Finished

    GuruFocus Article or News written by Nathan Parsh and the topic is about: The stock is up 16% since the earnings release, but could see double-digit returns on a modest multiple expansion.

  • Pfizer: The Rally Is Far From Finished
    gurufocus.com

    Pfizer: The Rally Is Far From Finished

    GuruFocus Article or News written by Nathan Parsh and the topic is about: The stock is up 16% since the earnings release, but could see double-digit returns on a modest multiple expansion.

  • Pfizer: The Rally Is Far From Finished
    gurufocus.com

    Pfizer: The Rally Is Far From Finished

    GuruFocus Article or News written by Nathan Parsh and the topic is about: The stock is up 16% since the earnings release, but could see double-digit returns on a modest multiple expansion.

  • Pfizer: The Rally Is Far From Finished
    gurufocus.com

    Pfizer: The Rally Is Far From Finished

    GuruFocus Article or News written by Nathan Parsh and the topic is about: The stock is up 16% since the earnings release, but could see double-digit returns on a modest multiple expansion.

  • Pfizer: The Rally Is Far From Finished
    gurufocus.com

    Pfizer: The Rally Is Far From Finished

    GuruFocus Article or News written by Nathan Parsh and the topic is about: The stock is up 16% since the earnings release, but could see double-digit returns on a modest multiple expansion.

  • Mayo Investment Advisers Llc Buys Vertex Pharmaceuticals Inc, Vistra Corp, Berkshire Hathaway Inc, Sells The Mosaic Co, Apple Inc, Alphabet...
    gurufocus.com

    Mayo Investment Advisers Llc Buys Vertex Pharmaceuticals Inc, Vistra Corp, Berkshire Hathaway Inc, Sells The Mosaic Co, Apple Inc, Alphabet Inc

    GuruFocus Article or News written by insider and the topic is about:

  • Kore Private Wealth LLC Buys Invesco Russell 1000 Dynamic Multifactor ETF, Coinbase Global Inc, Chevron Corp, Sells iShares Gold Trust, ,...
    gurufocus.com

    Kore Private Wealth LLC Buys Invesco Russell 1000 Dynamic Multifactor ETF, Coinbase Global Inc, Chevron Corp, Sells iShares Gold Trust, , PowerShares QQQ Trust Ser 1

    GuruFocus Article or News written by insider and the topic is about:

  • Pfizer and Biontech submit vaccine booster data in US, poorer nations fall behind
    themarketherald.com.au

    Pfizer and Biontech submit vaccine booster data in US, poorer nations fall behind

    Pfizer (NYSE: PFE) and BioNTech (Nasdaq: BNTX) have submitted phase 1 data to the US regulator on a third 'booster shot' of their COVID-16 vaccine.

  • U.S. administers 357.29 million doses of COVID-19 vaccines
    investing.com

    U.S. administers 357.29 million doses of COVID-19 vaccines

    U.S. administers 357.29 million doses of COVID-19 vaccines – CDC

  • Pfizer Prices $1.0 Billion Sustainability Bond
    thestreet.com

    Pfizer Prices $1.0 Billion Sustainability Bond

    Pfizer Inc. PFE today announced the pricing of a sustainability bond of $1,000,000,000 in aggregate principal amount of 1.750% senior notes due 2031.
    The

  • Pfizer Prices $1.0 Billion Sustainability Bond
    thestreet.com

    Pfizer Prices $1.0 Billion Sustainability Bond

    Pfizer Inc. PFE today announced the pricing of a sustainability bond of $1,000,000,000 in aggregate principal amount of 1.750% senior notes due 2031.
    The

  • Pfizer Prices $1.0 Billion Sustainability Bond
    thestreet.com

    Pfizer Prices $1.0 Billion Sustainability Bond

    Pfizer Inc. PFE today announced the pricing of a sustainability bond of $1,000,000,000 in aggregate principal amount of 1.750% senior notes due 2031.
    The

  • Pfizer Prices $1.0 Billion Sustainability Bond
    thestreet.com

    Pfizer Prices $1.0 Billion Sustainability Bond

    Pfizer Inc. PFE today announced the pricing of a sustainability bond of $1,000,000,000 in aggregate principal amount of 1.750% senior notes due 2031.
    The

  • Pfizer Prices $1.0 Billion Sustainability Bond
    thestreet.com

    Pfizer Prices $1.0 Billion Sustainability Bond

    Pfizer Inc. PFE today announced the pricing of a sustainability bond of $1,000,000,000 in aggregate principal amount of 1.750% senior notes due 2031.
    The

  • Pfizer Prices $1.0 Billion Sustainability Bond
    finanzen.net

    Pfizer Prices $1.0 Billion Sustainability Bond

    Pfizer Prices $1.0 Billion Sustainability Bond | Nachricht | finanzen.net

  • Banks are already bracing for a September leveraged buyout boom
    autofinancenews.net

    Banks are already bracing for a September leveraged buyout boom

    Banks are increasingly selling off short-term loans they made to fund leveraged buyouts, a sign that they’re freeing up capacity to lend even more in the coming months. Lenders are distributing $7.8 billion of such loans for the leveraged buyout of Medline Industries Inc., the biggest since the global financial crisis. Wells Fargo is selling a $1.475 billion short-term […]

  • Pfizer, BioNTech Seek FDA Clearance for Covid-19 Booster
    online.wsj.com

    Pfizer, BioNTech Seek FDA Clearance for Covid-19 Booster

    Data from an early-stage study shows that a third vaccine dose offers a higher level of protection, the companies say.

  • BioNTech-Aktie knickt ein: BioNTech/Pfizer reichen erste Daten zur Auffrischungsimpfung bei FDA ein
    finanzen.net

    BioNTech-Aktie knickt ein: BioNTech/Pfizer reichen erste Daten zur Auffrischungsimpfung bei FDA ein

    Das deutsche Unternehmen BioNTech und sein US-Partner Pfizer haben erste Daten für die Zulassung einer Auffrischungsimpfung gegen das Coronavirus bei der US-Arzneimittelbehörde FDA eingereicht. 16.08.2021

  • Boyd Gaming : to Host Public COVID-19 Vaccination Sites in August
    marketscreener.com

    Boyd Gaming : to Host Public COVID-19 Vaccination Sites in August

    LAS VEGAS-To help in the ongoing fight against the COVID-19 pandemic, Boyd Gaming will host four COVID-19 vaccination sites at its properties across the Las Vegas Valley later this month.

    … | August 16, 2021

  • Pfizer submits initial data for COVID-19 vaccine booster authorization
    financialpost.com

    Pfizer submits initial data for COVID-19 vaccine booster authorization

    Pfizer Inc and its German partner BioNTech SE have submitted to U.S. regulators the initial data from an early-stage trial toward seeking authorization of a…

  • Pfizer, BioNTech File Initial Data to FDA to Support Covid-19 Vaccine Booster Dose
    marketscreener.com

    Pfizer, BioNTech File Initial Data to FDA to Support Covid-19 Vaccine Booster Dose

    By Colin Kellaher

    Pfizer Inc. and BioNTech SE on Monday said they have submitted Phase 1 data to the U.S. Food and Drug Administration to support the evaluation of a booster dose of their… | August 16, 2021

  • Carts Lined Up For Retail Earnings, But Foreign Affairs First In Checkout Line
    investing.com

    Carts Lined Up For Retail Earnings, But Foreign Affairs First In Checkout Line

    Stocks Analysis by TD Ameritrade (JJ Kinahan) covering: S&P 500, Bank of America Corp, Microsoft Corporation, Cisco Systems Inc. Read TD Ameritrade (JJ Kinahan)'s latest article on Investing.com

Schreibe einen Kommentar

Wenn du schon einen Account hast, logge dich ein bevor du den Kommentar absendest.

Galue Account Vorteile
  • Battles

    Messe dich mit der Community in Battles.

  • Badges

    Erhalte Belohnungen für Kommentare, die der Community helfen.

  • Mehr Informationen für alle

    Poste Bilder oder Videos zu Themen und Unternehmen und helf dabei, dass Investoren ein kontroverseres Bild erhalten.

  • Kein Datenrisiko

    Du kannst jederzeit deinen Account löschen und gespeicherte Daten einsehen.

Portrait der Pfizer Aktie

Das Unternehmen Pfizer Inc aus USA beschäftigt 83.400 Mitarbeiter und ist in den Bereichen Chemie & Pharma, Biotechnologie, Pharma tätig.

Tochterunternehmen von Pfizer sind: Pfizer Ltd/India, PFIZER LTD., Pfizer Limited.

Das Unternehmen Pfizer Inc ist in mehr als 89 ETFs enthalten und somit ein eher allgemein bekannter Wert. Der Spitzenreiter VanEck Vectors Morningstar Durable Dividend ETF gewichtet Pfizer mit 5,94% im ETF.

Es ist auch möglich über Anleihen zu investieren. Hier findest du alle Pfizer Anleihen auf einen Blick.

Entdecke die 6 ETFs in denen Pfizer Inc am höchsten gewichtet ist Insgesamt in 89 ETFs enthalten

Dir gefallen die Informationen zu Pfizer?

Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn Ihr meine Arbeit unterstützen möchtet, dann eröffnet gerne ein kostenloses und unverbindliches Depot bei Trade Republic mit der Möglichkeit kostenlos Aktien zu besparen. Wenn du das über meinen Link machst, bekommst du und ich bei deinem ersten Wertpapierkauf 15 von Trade Republic geschenkt:

Zu Trade Republic

Dir gefallen die Informationen zu Pfizer?

Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn Ihr meine Arbeit unterstützen möchtet, dann eröffnet gerne ein mindestens 3 Jahre lang kostenloses Depot bei der comdirect. Wenn du das über diesen Link machst unterstützt du auch meine Tochter Zoe, da es Ihr Juniordepot ist. Sie erhält 20 und bei einem aktiven ETF- oder Aktien-Sparplan bleibt dein Depot auch danach kostenfrei:

Zur Comdirect

Dir gefallen die Informationen zu Pfizer?

Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn du meine Arbeit unterstützen möchtest, dann eröffne ein kostenloses und unverbindliches Depot bei BUX Zero mit der Möglichkeit kostenlos US-Aktien und für einen Euro viele weitere Aktien aus Deutschland, Belgien, Niederlande, sterreich oder UK zu kaufen. Wenn du das über meinen Link machst, bekommen wir beide eine gratis Aktie geschenkt:

Zu BUX Zero

Dir gefallen die Informationen zu Pfizer?

Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn du meine Arbeit unterstützen möchtest, dann eröffne gerne ein kostenloses und unverbindliches Depot bei der ING Diba. Ich erhalte 20 wenn du daraufhin dann zum Beispiel einen Aktien-Sparplan anlegst oder etwas kaufst:

Zur ING Diba